Avricore Health Inc. (AVCR.V) Research

Avricore Health Inc. operates within Canada, specializing in health data management and point-of-care technological solutions. Their primary offering is HealthTab, a precise, laboratory-quality diagnostic testing system designed for use in pharmacies. This enterprise maintains key alliances with prominent organizations such as Shoppers Drug Marts and Abbott. Established in 1996 and headquartered in Vancouver, Canada, the company previously operated as Vanc Pharmaceuticals Inc., adopting its current name, Avricore Health Inc., in October 2018.

Market snapshot

Symbol
AVCR.V
Price
$0.06
Day change
+10.00%
Market cap
$5.6M
P/E ratio
-2.82x
52-week range
0.045-0.1
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Next earnings
in 2 months

Peer companies

  • Aptose Biosciences Inc. (APS.TO)
  • CanadaBis Capital Inc. (CANB.V)
  • CordovaCann Corp. (CDVA.CN)
  • Kane Biotech Inc. (KNE.V)
  • Mercanto Holdings Inc. (MUSH.V)
  • Mountain Valley MD Holdings Inc. (MVMD.CN)
  • Revive Therapeutics Ltd. (RVV.CN)
  • Telo Genomics Corp. (TELO.V)

Open Avricore Health Inc. (AVCR.V) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.